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[3H]inositol and 32Pi were simultaneously incorporated into rat parotid phosphatidylinositol. The ratio of 
[3H]/32Pi incorporation dropped dramatically following stimulation with muscarinic or a-adrenergic 
agonists and returned to control values following the addition of appropriate antagonists. The drop in 
[3H]/32Pr ratio can be explained by a rapid increase in de- novo synthesis ofphosphatidylinositol f l owing 
its receptor-mediated breakdown. The change in this ratio also provided evidence for the existence of 
CDP-DC + inositol P phosphatidylinositol exchange reaction in the intact tissue. 
Phosphatidylinositol LvAdrenergic 
1. INTRODUCTION 
Cholinergic and a-adrenergic stimulation of rat 
parotid slices results in a rapid release of in- 
tracellular K+ [l] and in the increased incorpora- 
tion of 32Pi into phosphatidylinositol (PI) [2,3]. 
The increased incorporation of radioactive 
phosphate into PI (phospholipid effect) was first 
reported in [4] and is the common biochemical 
event which accompanies stimuli that elicit their 
response through the mobilization of Ca*+ [5,6]. 
This is preceded, in many instances, by a decrease 
in tissue PI [7,8]. 
The disappearance of tissue PI may reflect the 
breakdown of this phospholipid and this reaction 
may be involved in the molecular mechanism of 
the increased permeability of the cell membrane to 
Ca*+ 191. Inositol can be incorporated into PI by 
an exchange reaction via the reversal of the biosyn- 
thetic pathway [lo]. There are, therefore, two 
possible pathways for the decrease in tissue PI; 
hydrolytic breakdown catalyzed by a 
phospholipase or the reversal of the biosynthetic 
reaction resulting in the accumulation of CDP- 
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diacylglycerol (CDP-DG). Consequently, there are 
two possible pathways for PI resynthesis; de novo 
synthesis from diacylglycerol or only the final step- 
yielding PI from CDP-DG and free inositol. 
This work provides evidence for the existence of 
the exchange reaction in the intact cell, and that 
the increased incorporation of [3H]inositol into PI, 
following cholinergic or o-adrenergic stimulation, 
represents de novo synthesis rather than an in- 
crease in the exchange reaction. 
2. METHODS 
Parotid glands were excised and incubated as in 
[3,11], except that the bicarbonate was replaced by 
25 mM Hepes buffer (pH 7.45) and the gas mix- 
ture changed to pure oxygen. Parotid slices were 
labelled with [‘Hlinositol (New England Nuclear 
or Amersham) or 32 Pi (Nuclear Research Center, 
Negev) at 100 &i/ml and 240 &i/ml, respective- 
ly. [‘4C]Glucose (uniformly labelled) was the pro- 
duct of New England Nuclear. 
Following incubation gland slices were 
homogenized in 1 ml cold water, an aliquot was 
withdrawn for protein determination according to 
[12], then trichloroacetic acid was added to a final 
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concentration of 5%. The homogenate was cen- 
trifuged (1500 x g for 10 min) and the resulting 
pellet was extracted twice with chloroform:me- 
than01 (2 : 1, v/v). Phospholipids were separated 
by two-dimensional thin-layer chromatography 
[chloroform : methanol :acetic acid : Hz0 = 25 : 15 : 
4 : 2 (by vol.) in the first dimension, IO cm; chloro- 
form : methanol :NHdOH : EDTA 5mM = 
30: 10: 1: 1 (by vol.) in the second dimension, 
20 cm] on Riedel-De Haen plates (no.37351). The 
PI spot was identified with iodine vapors by co- 
chromatography with a marker (Sigma, Israel), 
scraped out and counted in a liquid scintillation 
counter (Packard) in a double-label (3H/32P) 
mode. 32Pi uptake was estimated by counting the 
trichloroacetic acid supernatant of the homo- 
genate. 32P content of the nucleotide fraction was 
estimated by adsorption on activated charcoal. 
All chemicals were of analytical grade, Drugs 
were obtained from Sigma and Regis. Statistical 
analyses were performed using paired and un- 
paired Student’s t-test. 
3. RESULTS AND DISCUSSION 
Rat parotid slices incorporated f3H]inositol into 
PI. The rate of incorporation was constant up to 
180 min incubation. When gland slices were expos- 
ed to carbamylcholine and then to atropine and 
[3H)inositol, the rate of label incorporation into PI 
was significantly higher than that of control gland 
slices (fig. 1). Similar results were obtained follow- 
ing ar-adrenergic stimulation and blockade (not 
shown). This increase was compatible with 
cholinergic breakdown of PI [ 131 and its subse- 
quent re-synthesis. Cholinergic stimulation (car- 
bamylcholine 0.1 mM, 20 min) resulted in a mark- 
ed increase in the incorporation of both t3H]in- 
ositol(280 f 110% over controls, 7 expt) and 32P, 
(550 + 60% over controls, 7 expt) into tissue PI. 
The increased incorporation of [3H]inositol into PI 
was investigated using a double-label technique. 
Parotid slices were incubated with [3H]inositol and 
32Pi simultaneously and the incorporation into PI 
assayed in control glands and following (Y- 
adrenergic or cholinergic stimulation. The relative 
incorporation of inositol and phosphate into PI 
was defined by the ratio {R) of 3H and 32P counts 
incorporated into the same chromatographic spot 
of PI. This ratio decreased ramatically upon the 
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Fig.1. The incorporation of [3H]inositol into rat parotid 
slices. Parotid slices were prepared and incubated as in 
section 2. The tissue was incubated either without any 
additions (squares) or with c~b~yl~holine (100 pM, 
circles) for 30 min. At that time atropine (10 FM) was 
added with [‘H]inositoi (l~~Ci/ml) and its 
incorporation into PI was determined at the indicated 
times. The results are the mean of 3 expt and are 
presented as 9’0 total label incorporated into PI. Paired 
Student’s t-test was used and the incorporation was 
significantly higher @ < 0.05) in tissue pre-exposed to 
carbamylcholine. 
exposure of gland slices to carbamylcholine, or 
epinephrine and propranolol (to ensure LY- 
adrenergic stimulation). The decrease in R was 
blocked by the specific muscarinic and a- 
adrenergic blockers, atropine and phentolamine, 
respectively. The antagonists alone did not affect 
the ratio (fig.2). The decrease in R caused by car- 
bamylcholine could be reversed by the addition of 
atropine (fig.3). The initial rise in R during the first 
45 min of incubation with the radio-labels could be 
explained by a more rapid equilibration of the in- 
tracellular phosphate pool with the external abel. 
The decrease in the ratio of incorporation of 
[3H]inositol/3zPi into PI could be interpreted in 
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several ways. An increase in the specific radioac- 
tivity of the cellular ATP pool due to the 
cholinergic or cu-adrenergic K+ release and the 
stimulation of Na+/K+-ATPase, or an increase in 
32Pi uptake could provide a trivial explanation. 
However, no increase in the specific radioactivity 
of ATP upon a-adrenergic stimulation was 
reported in [2]. Moreover, we measured 32Pi up- 
Fig.2. Decrease in the ratio of [3H]inositol/32Pi (R) 
incorporation into PI in rat parotid slices upon cy- 
adrenergic orcholinergic stimulation. Parotid slices were 
incubated in the presence of [‘Hlinositol (100 &i/ml) 
and “Pi (250,Ki/ml) for 20 min. Tissue samples were 
processed and analyzed for the incorporation of both 
isotopes into PI as in section 2. The ratio (I?) of 
incorporation in control tissue (no additions) was 
assigned the value of 100% and the other group 
treatments were normalized accordingly. The bars 
represent he means f SEM of 3-7 expt performed in 
triplicate. Unpaired Student’s t-test was used to calculate 
the significance of differences between the experimental 
systems and the control; * p < 0.01; ** not significantly 
different from control. 
take and found that it decreased, rather than in- 
creased upon cholinergic stimulation (not shown). 
We have also conducted experiments similar to 
those shown in fig.2 in the absence of Ca2+ and in 
the presence of EGTA in the medium (to abolish 
K+ efflux and the associated activation of 
Na+/K+-ATPase), as well as following the 
removal of extracellular label, which prevented 
any change in the specific radioactivities of the in- 
tracellular pools. In both types of experiments the 
results were qualitatively unchanged (table 1). The 
decrease in R could also be the result of a large 
decrease in the specific radioactivity of the in- 
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Fig.3. The kinetics of the ratio of incorporation of [3H]inositol/32Pi n rat parotid gland. Gland slices were incubated 
with [3H]inositol and 32P,. Carbamylcholine (100 PM) was added at 45 min incubation, and atropine (10 /tM) at 80 min. 
At the indicated times samples were withdrawn and the ratio of [3H]inositol/32Pr incorporation into PI was determined 
as in fig.2 and section 2. All results were normalized to the value of R at 20 min incorporation, which has been assigned 
an arbitrary value of 100%. The points represent he means f SEM of a number of experiments given at each point. 
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Table 1 
The decrease in the ratio of incorporation of 
[3H]inositol/32Pr into PI in rat parotid slices in the 
absence of Ca2+, or after the removal of the radioactive 
label 
Treatment (N) R = ratio of incorporation of 
3H/32P into PI 
Control Carbamyl- p 
choline 
None (6) 12.0 + 1.9 5.2 + 0.6 <O.Ol 
No Ca2+ + EGTA (6) 22.7 f 1.6 5.9 + 0.5 <O.Ol 
Wash (6) 10.0 f 0.4 3.4 f 0.2 <O.Ol 
Parotid slices were incubated as described in fig.2 (no 
treatment), without Ca2+ and in the presence of 1 mM 
EGTA, or were washed thoroughly with non-radioactive 
medium before the addition of drugs. Carbamylcholine 
was 100 PM. The results are the means + SEM of 3 expt. 
Statistical significance was determined by unpaired 
Student’s t-test 
tracellular pool of inositol. This could be effected 
by a massive synthesis of inositol. [r4C]Glucose 
was incorporated only slightly into PI (most pro- 
bably into the glycerol moiety). This incorporation 
did not increase upon cholinergic stimulation. 
It appears, therefore, that the only valid inter- 
pretation of changes in R is a change in the relative 
rates of de novo synthesis and exchange reactions. 
Two major conclusions can be drawn from these 
results: 
(1) The CDP-DG + inositol 6 PI + CMP ex- 
change reaction was previously demonstrated in 
cell-free preparations [10,141, and by inference, in 
the intact cell [15]. To the best of our knowledge, 
this is the first direct demonstration of this reac- 
tion in the intact cell. 
(2) The disappearance of PI upon hormonal 
stimulation is a common early event in many 
tissues. Our results can rule out the reversal of the 
biosynthetic pathway as a possible mechanism. 
The breakdown of PI by a phospholipase C-type 
enzyme, the concomitant release of diacylglycerol, 
and the subsequent de novo synthesis of PI appear 
to be more likely. The reports of the accumulation 
of inositol-phosphate [ 161, particularly when 
phosphatase is inhibited by Li ([ 17-191, and 
Hokin-Neaverson and Eisenberg, personal com- 
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munication) are thus confirmed. The overall 
relevance of the PI breakdown to the calcium- 
gating process remains, however, to be elucidated. 
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